Petadeferitrin is an orally bioavailable iron-chelating agent derived from desferrithiocin. It binds free iron, promoting its excretion and reducing iron accumulation and tissue damage in iron overload. It is studied in beta thalassemia major anemia and myelodysplastic syndrome.
Summary written with AI from the sources listed at the end of this page.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.